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Omnipresent mRNP QC
The life of a eukaryotic mRNA is astonishingly complex: from its birth in the nucleus to its cytoplasmic demise it undergoes a series of interconnected biochemical reactions, starting with its synthesis by RNA polymerase II (RNAPII), followed by the transcription-coupled addition of a 7-methylguanylate cap to its 5' end, removal of its introns and cleavage and polyadenylation of its 3' end [1] [2] [3] . In addition to these covalent chemical changes, each mRNA has to correctly interact with a specific ensemble of RNA-binding proteins to form the mRNP that constitutes the functional entity of the message. Some of these proteins accompany the mRNA all the way until it is translated or degraded, while others associate in a location-specific or temporal manner to convey properties to the mRNP of only transient utility.
Regardless of their exact nature, steps in the biogenesis and remodelling of mRNPs are susceptible to mistakes. To reduce the error frequency of the steady-state mRNP population, cells have evolved QC systems at several levels in both the nucleus and in the cytoplasm [4] [5] [6] [7] ( Figure 1 ). These often take advantage of the normal reactions of mRNP biogenesis or utility where the welfare of the concerned mRNP is directly revealed. Indeed, most QC systems described so far intervene if the efficiency by which the mRNP is produced and transported is inadequate or if it performs poorly in translation.
Current examples of QC checkpoints include the processes of mRNA capping 8, 9 , splicing 10 , 3'-end formation [11] [12] [13] [14] [15] , mRNP nuclear exit [16] [17] [18] and interaction with ribosomes [19] [20] [21] [22] [23] [24] [25] .
For an in-depth discussion of the constituent factors of QC systems and their mechanisms of action, we refer the reader to recent reviews on nuclear [5] [6] [7] and cytoplasmic QC [26] [27] [28] [29] [30] . Here, we emphasize that QC systems are not dedicated entities evolved only to survey mRNP performance. Instead, QC is often based on the somewhat surprising intimate connection between common cellular RNA degradation activities and factors involved in productive mRNP transactions. In fact, degradation factors, or the proteins recruiting them, often participate themselves in mRNP production or remodelling. The term QC therefore often describes a competition between the opposing processes of biogenesis/function and turnover, which permits the elimination of molecules or complexes that do not meet certain standards. Interestingly however, although QC processes normally serve to remove aberrant material, they can be readily exploited by the cell to also serve gene regulatory purposes, and because most mRNP biogenic and metabolic activities are functionally intertwined 2, 3 , there is ample opportunity for such regulation.
Here, we aim to illustrate this concept by recently published examples.
Balancing biogenesis and function with decay
Whenever an mRNP fails to pass QC, its progression is restricted with the typical result that its mRNA component is degraded by ribonucleases. 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64  65 Mühlemann & Jensen, TiG review, 5 6, 32 ). The outcome of this competition between normal maturation/function and commitment to mRNA degradation can be viewed as a double pan balance in which one pan contains mRNPs that passed QC and the other contains complexes whose mRNAs are destined for degradation ( Figure 2 ).
For any individual mRNP species, the fraction ending up in either pan of the balance ultimately depends on the competing rate constants, which we refer to as k normal (rate constant for the normal maturation step or function) and k aberrant (rate constant for commitment to mRNA decay). Although QC systems
are not yet understood in sufficient detail to allow a precise determination of these rate constants and make quantitative statements, they are still very useful as tools for discussion. Due to the inherent error rate of every step of mRNA production and mRNP assembly, any population of a specific mRNP species will harbour a fraction of particles that are defective or have reduced functionality. These mRNPs have a lower k normal /k aberrant ratio compared to their flawless mRNP cousins, resulting in their differential distribution between the two pans and hence in efficient QC (Figure 2A ). For example, aberrant mRNPs may be less efficient substrates for the processing reaction or functional activity in question (i.e. a reduced k normal ) or they may have acquired degradation-promoting features (i.e. an increased k aberrant ). Notably, when the overall capacity of a particular decay pathway is exceeded because of suboptimal mRNP production/function and/or because a key degradation factor is inactivated, aberrant mRNAs will accumulate in the cell. Indeed, it is under such conditions that most QC pathways have been revealed experimentally.
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If we apply the double pan balance concept to the entire cellular population of particles, each mRNP species will have its own intrinsic average k normal /k aberrant ratio that determines which fraction will survive a given QC checkpoint. Thus, extrinsically induced changes affecting the overall assembly, processing or degradation rates, e.g. by modification of the activity of an enzyme required for mRNP production/function or decay, will alter the species-specific k normal /k aberrant ratio and hence the proportion of surviving mRNPs ( Figure 2B ). This is because mRNA-inherent features influencing k normal or k aberrant are diverse and of different strengths, hereby providing a wide and gradual spectrum of possible responses to e.g. stress or changed growth conditions. The concentration of a single mRNP species may also be specifically regulated via alteration of one or several of its constituents, changing the k normal and/or k aberrant of that species only. In such considerations, the system controls gene expression and the distinction between mRNP QC and gene regulation becomes arbitrary.
Nuclear QC systems at work
As a general nuclear surveillance measure, QC systems in this locale efficiently remove mRNAs undergoing slow or aberrant 5' capping, splicing or 3'-end formation (reviewed in 6, 33 Mühlemann & Jensen, TiG review, 7
portions of eukaryotic genomes are transcribed, often on both strands and in a quite promiscuous manner [34] [35] [36] . Presumably via binding to the A 26 sequence, rising levels of Nab2p prevents polyadenylation at this site and instead shifts the balance towards Rrp6p-dependent degradation of NAB2 mRNA. The mechanism by which Nab2p
sensitizes the transcript to exosomal-decay is not known, but may depend on the ability of Nab2p to recruit Rrp6p (THJ, unpublished observation). Mühlemann & Jensen, TiG review, 9
Moreover, this involvement of QC factors in the 'normal' 3' end formation process appears to be of a broader nature as a related phenomenon has been reported for the S. cerevisae CTH2 mRNA 5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64  65 Mühlemann & Jensen, TiG review, 10 traditional view that nuclear PABPs solely function in poly(A) tail biogenesis of regular mRNA: they may in addition facilitate the recruitment of QC factors, resulting in mRNA decay unless the targeted mRNP has evolved other means to deflect this nuclear ribonucleolytic challenge (e.g. preventive cis-elements or trans-factors, or a rapid expedition into the cytoplasm) 58 .
Shifting the balance: Modification of QC activity
Gene expression control by altering nuclear QC activity has been well documented in the yeasts S. cerevisiae and S. pombe. It is based on the widespread antisense (as) transcription of these genomes and the ability of RNA degradation activities to rapidly alter cellular levels of such molecules [59] [60] [61] [62] [63] [64] . A prime example is the as-transcription through the S. cerevisiae PHO84 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64  65 Mühlemann & Jensen, TiG review, 11
As diploid cells lacking Rrp6p cannot undergo efficient meiotic development, this sudden switch in the nuclear repertoire of ncRNA may have important consequences for the meiotic gene expression program.
A related example is provided by the asRNA-mediated regulation of S.
cerevisiae GAL genes required for galactose metabolism 61 . Even after mRNPs engage with the translation apparatus, QC ensues.
Failure of ribosomes to terminate translation properly commonly triggers the rapid destruction of the concerned mRNA 1, 4, 26 , which under certain conditions is accompanied by degradation of the involved ribosomes 66, 67 .
Well documented examples include transcripts harboring a premature termination codon (PTC) targeted by nonsense-mediated decay (NMD) 29 ), mRNAs that lack a termination codon targeted by nonstop mRNA decay (NSD) 19, 20 , and mRNAs with ribosomes stalled at stable secondary structures or at a stretch of rare codons targeted by no-go mRNA decay (NGD) 21 .
Recent studies suggest that NSD and NGD might be mechanistically related processes. First, translation of the poly(A) tail of a nonstop mRNA generates a poly-lysine chain that was reported to stall ribosomes by clogging their exit tunnels 68 , which essentially creates a no-go situation. Second, NSD and NGD both involve the release factor eRF1 homolog Pelota (Dom34p in yeast) and the eRF3 homologous GTPase Hbs1p 21, 69 . In addition to these two release factor-mimicking proteins 70, 71, 72 , the yeast E3 ubiquitin ligase
Ltn1p was recently found to mark the nascent peptides produced from nonstop mRNAs for proteasomal degradation 68 , revealing an interesting conceptual analogy to the bacterial tmRNA-based surveillance system. In bacteria, a unique bi-functional aminoacylated transfer-messenger RNA (tmRNA) binds to the stalled ribosome, allows it to resume translation and serves as a template for addition of a peptide tag to the nascent polypeptide chain that induces its rapid proteolysis 73 . Concerning k normal /k aberrant ratios (Figure 2 ), nonstop mRNAs are presumably efficiently recognized aberrant 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64 ).
Physiological NMD targets are usually downregulated moderately (2 -5 fold, 76 ), whereas classical PTC-containing substrates tend to swing the balance towards decay more dramatically by reducing transcript levels 10 -50 fold.
The precise mode of selecting mRNAs for the NMD pathway is not yet understood. However, data from both S. cerevisiae and human cells suggest an evolutionarily conserved core mechanism at the heart of which there is a kinetic competition between PABPC1 (the major human cytoplasmic PABPPab1p in yeast) and the NMD factor UPF1 for a mutually exclusive interaction with eRF3 (Sup35p in yeast) 77, 78 ( Figure 5 ). According to this model, the 3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64  65 Mühlemann & Jensen, TiG review, 14 eRF3-PABC1 interaction is required for proper mRNA translation termination, while the competing eRF3-UPF1 interaction represents the first step towards NMD (reviewed in 79, 80 ). A key determinant for efficient eRF3-PABPC1 interaction is the physical distance between eRF3 bound to the ribosome stalled at the termination codon and PABPC1 bound to the poly(A) tail. The larger this distance, the less efficient is the eRF3-PABPC1 interaction, increasing the likelihood of UPF1 interference and congregation of other NMD components. Consequently, any mRNP rearrangements that alter the structure of the 3' UTR are predicted to affect mRNA half-life and comprise a possibility for gene regulation 80, 81 . This mode of regulation has so far only been demonstrated with engineered reporter gene constructs 81 and physiological examples are awaiting discovery.
After identification as an NMD substrate (i.e. after sorting to the right pan in Figure 2A ), the RNA moiety of the mRNP is degraded in different ways depending on the species. In yeast, degradation of NMD substrates involves deadenylation, decapping and exonucleolytic decay [82] [83] [84] [85] . In Drosophila and human cells, the metazoan-specific NMD factor and endonuclease SMG6 cuts substrates in the vicinity of the stalled ribosome [86] [87] [88] , although there is also evidence for exonucleolytic decay triggered by deadenylation and decapping in human cells [89] [90] [91] 92 .
Given its role as an effector of 3 -10 % of all cellular mRNAs 75 , the activity and substrate selectivity of the NMD system is expected to be controlled by extrinsic signals. For example, during the differentiation of myoblast cells to myotubes, the overall efficiency of NMD diminishes as a consequence of the instigation of another mRNA turnover process called 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64  65 Mühlemann & Jensen, TiG review, 15
Staufen-mediated mRNA decay, which competes for the rate-limiting UPF1
protein. This leads to de-repression of the myogenin mRNA, which encodes a protein required for myogenesis 93 . Similarly, cellular stress such as hypoxia or amino acid deprivation has also been found to reduce NMD potency, resulting in increased levels of numerous mRNAs encoding proteins associated with the respective stress response 94, 95 . 
Concluding remarks
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